share_log

A股细胞免疫治疗概念走高 冠昊生物20CM涨停

The concept of A-share cell immunotherapy is rising, and guanhao biotech's stock price has risen by 20%

Gelonghui Finance ·  Sep 2 09:36

On September 2, Guanhao Biotech and Nanhua Bio rose by the daily limit, Tailin and Canature Health rose by more than 10%, and Zhongyuan Xiehe, Chitianhua, and Nanjing Xinjiekou department store surged rapidly. On the news front, the 3rd Tianfu Stem Cell and Cell Therapy Conference will be held from September 6th to 8th. It is reported that this conference will focus on the theme of "Collaborative Innovation of Medical Science and Technology and Integrated Development of the Health Industry", focusing on cutting-edge scientific issues in the field of biomedicine and stem cells, and showcasing the latest achievements and important progress in research in the field of biomedicine and stem cells.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment